N

Northwestern Medicine

Academic medical center research, teaching, care

Patient Care Technician

Full-TimePosted on 10/15/2026
$18.33 - $24.75/hr
Entry
Palos Heights, IL, USA
In Person
Medical, Clinical & VeterinaryNursing & Frontline Patient Care

About the job

Requirements
  • High school diploma or equivalent.
  • Certified Nursing Assistant, Certified Medical Assistant, Emergency Medical Technician, or nursing school student with one semester of clinical experience completed.
  • American Heart Association Basic Life Support (BLS).
Responsibilities
  • Perform basic nursing care activities as delegated and supervised by a registered nurse, including monitoring vital signs, taking blood glucose measurements, and recording intake and output.
  • Assist patients with personal care and activities of daily living, including bathing, grooming, and eating.
  • Report abnormal findings or changes in patients’ physical, mental, and emotional conditions to nursing staff.
  • Help keep patient rooms clean and orderly.
  • Prioritize and complete unit work promptly as the needs of the unit, patients, and staff change.
  • Serve as a liaison between patient care units and other patient-related departments.
  • Answer telephone, intercom, and call lights politely, using appropriate telephone etiquette, and communicate information to appropriate staff, family, or patients.
  • Manage overall unit workflow with the charge registered nurse and/or assistant manager as needed.
  • Perform pre-census tasks and validate daily admission, discharge, and census lists as needed.
Desired Qualifications
  • Phlebotomy experience.
  • Graduation from an accredited Nursing Assistant program or completion of a Phlebotomy course.

About the company

Northwestern Medicine brings together Northwestern Memorial HealthCare and the Northwestern University Feinberg School of Medicine to advance health care through research, teaching, and patient care. It runs an academic medical system with more than 33,000 staff, faculty, students, and researchers across 200 locations, including five hospitals that are ranked among America’s Best by U.S. News & World Report (2025–2026). The organization offers medical care by clinicians and scientists who also teach and study new treatments, meaning patients may benefit from up-to-date therapies developed through ongoing research. Its approach combines hospital services, medical education, and scientific discovery in one ecosystem, which sets it apart from ordinary clinics. The goal is to improve medicine so that patients receive higher-quality care and safer, better outcomes.

Company Size

10,001+

Company Stage

Grant

Total Funding

$25M

Headquarters

Chicago, Illinois

Founded

2009

Get referred to Northwestern Medicine

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • A June 16, 2026 $35 million Schreiber gift funds community health expansion.
  • Vizlitics activated cancer trial matching on June 18, 2026, improving enrollment efficiency.
  • The 330 E. Erie tower targets 2031 completion, adding 1.2 million square feet.

What critics are saying

  • EEOC settled August 2026 religious discrimination charges for $325,000 and policy retraining.
  • Union workers at Northwestern Memorial demanded more ER staff on January 7, 2026.
  • The 330 E. Erie tower still needs zoning and a fall 2026 Certificate of Need.

What makes Northwestern Medicine unique

  • Northwestern Medicine pairs Feinberg research with 33,000 employees and 5,400 aligned physicians.
  • Its Techstars accelerator opened August 24, 2026, embedding startups inside Chicago clinicians.
  • The Streeterville tower links inpatient, oncology, imaging, and surgery through campus bridges.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options
  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Vacation
  • Paid Holidays
  • Flexible Work Hours
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Wellness Program
  • Mental Health Support
  • Job Training or Education?

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-14%

2 year growth

1%
HyperAI
Oct 16th, 2026
Command palette.

Command palette. 2 hours ago Northwestern Medicine researchers and collaborating institutions have developed an artificial intelligence tool that helps identify harmful genetic variants in STXBP1, a gene commonly linked to severe childhood epilepsies, potentially improving diagnosis and eligibility for emerging precision therapies. The study, published in the Journal of Clinical Investigation, introduces EpiPred, a supervised machine-learning model built to predict whether missense variants in STXBP1 cause disease rather than represent benign genetic differences. Senior author Gemma Carvill, associate professor of neurology, pharmacology and pediatrics at Northwestern Medicine, said the model addresses a major limitation of clinical genetic testing, where many variants remain classified as uncertain, leaving families without clear diagnoses or access to gene-targeted treatments. The research was conducted through a National Institutes of Health-funded collaboration involving Northwestern Medicine, the University of Michigan, Weill Cornell Medicine and St. Jude Children's Research Hospital. The team combined computational prediction with laboratory assays measuring protein abundance, stability, solubility and interaction with other cellular components. They also used cellular and animal models to validate the predictions. According to the researchers, EpiPred outperformed existing broad variant prediction tools in accuracy, sensitivity and specificity, and its results aligned closely with experimental findings. The model identified several variants that may have been misclassified in earlier studies, including cases in which individuals may have been incorrectly diagnosed with STXBP1-related disorder. Correcting such diagnoses could be critical as gene-targeted therapies enter clinical trials, because uncertain or incorrect variant interpretations can exclude patients from precision medicine programs. The investigators extended the analysis to hundreds of known variants and predicted the effects of all possible STXBP1 missense changes. They estimated that about one quarter of variants currently classified as uncertain may actually be disease-causing, a finding that could expand the number of patients receiving definitive diagnoses and qualifying for future treatments. The team also released an interactive web application allowing clinicians, researchers and families to explore STXBP1 variant predictions. Future work will use higher-throughput experimental systems capable of testing more than 3,000 possible missense variants in STXBP1 simultaneously. Carvill said the broader goal is to create a reproducible framework combining gene-specific artificial intelligence with large-scale laboratory validation, which could be applied to other rare neurodevelopmental disorders and rare genetic diseases generally.

AMCH
Oct 13th, 2026
Johns Hopkins has selected OpenEvidence, which is already used by 1.12 million medical professionals in the U.S.

Johns Hopkins has selected OpenEvidence, which is already used by 1.12 million medical professionals in the U.S. Johns Hopkins Medicine is launching a partnership with OpenEvidence focused on clinical practice and physician training, reports Fierce Healthcare. The parties will develop AI systems that integrate the evidence base with patient medical records and Johns Hopkins protocols, using them to build a new model of medical education. OpenEvidence describes Johns Hopkins as the birthplace of modern medical education. Recently, Northwestern Medicine announced that it had integrated OpenEvidence into its Epic electronic health record system. The service is accessible to nurses, pharmacists, and other clinical staff in addition to physicians, with access provided via hospital credentials. Prior to this, OpenEvidence had been adopted by Mount Sinai, Cedars-Sinai, Penn Medicine, NewYork-Presbyterian, and AdventHealth. OpenEvidence is free for US medical professionals; according to the company, 1.12 million licensed specialists used the platform in September. Integrations are moving the service from physicians' mobile phones into the operational systems of the country's largest health systems - and, through the Johns Hopkins partnership, into the training of the next generation of medical professionals. In September, Forbes reported that investors valued OpenEvidence at $15 billion, a 25% increase over its valuation in the January funding round. OpenEvidence is available in its app.

Yahoo Finance
Oct 12th, 2026
OpenEvidence embeds AI clinical search in Northwestern Medicine's Epic health records

Northwestern Medicine and OpenEvidence, an AI-powered medical search and clinical decision-support platform, have announced a collaboration to embed OpenEvidence directly in the electronic health record (EHR). Since October 8, clinicians at the Chicago health system can launch the tool from Epic, signed in automatically with their hospital credentials. Nurses, pharmacists and other clinical staff get access for the first time. Users can check medication dosing and drug interactions, review guidelines, and get cited answers drawn from peer-reviewed literature, including the New England Journal of Medicine and the JAMA Network. The enterprise-wide rollout is the first phase of a broader effort to ensure AI is used safely at the bedside. Northwestern Medicine runs 11 hospitals and more than 200 diagnostic and ambulatory sites.

STAT
Oct 6th, 2026
Can you live longer for $5,500? Longevity clinics are the buzzy new trend at nonprofit hospitals.

Can you live longer for $5,500? Longevity clinics are the buzzy new trend at nonprofit hospitals. Northwestern Medicine, Weill Cornell, and Mayo Clinic have all launched cash-pay longevity clinics. Oct. 6, 2026 Todd underwent longevity assessments at hospital clinics in two states for this story, measuring the health trajectories of her heart, brain, lungs, eyes, ears, and more, as well as her strength and fitness. This is Part 1 of Selling Longevity, which examines the science of longevity and the risk of jumping ahead of research in search of profits. CCHICAGO - I was walking briskly on a steep treadmill, wearing a mask that evoked the villain Bane from "Batman." Prince crooned back-handed compliments over an iPad speaker to keep my energy up, promising I had to be neither rich nor cool to be his girl. Every so often, the woman standing next to me asked me to point at the color-coded sheet ranking my state of exertion from 1 (roughly, "I could do this all day") to 10 ("I not only hate this but am about to keel over if you don't slow this thing down"). The goal was to get to 10. Pushing myself to achieve difficult physical goals does not come naturally. I can't go on, I thought. I went on. This was the VO2 Max test, which shows how efficiently the body uses oxygen ("V" stands for volume, "O2" for oxygen) and is considered medicine's most accurate measure of cardiorespiratory fitness. It was the last in a barrage of assessments I'd undertaken at a shiny longevity clinic affiliated with Northwestern University - part of a $5,500 annual package. The quest to defeat the indignities of aging has long provoked costly and questionable practices, from the 1920s doctors who believed in the rejuvenating power of grafted monkey testicles to Bryan Johnson's since-abandoned blood transfusions from his teenage son. Now some of the nation's most prestigious health systems are jumping into the growing business of longevity. They promise a rigorous scientific approach to helping people preserve their youthful vigor for as long as they can, with assessments that give patients more detailed pictures of their current physical conditions and aging trajectories than they'd get at a typical doctor's visit. Some critics, however, question how to reconcile the clinics' high out-of-pocket costs with hospitals' nonprofit status and charitable missions, and warn that in their zeal to attract paying customers, they're offering tests that lack sufficient evidence showing they actually improve people's health. * Sarah Todd Reporter, Commercial Determinants of Health Sarah covers how industries like food and tobacco affect Americans' bodies and minds. Her interests include ultra-processed foods; smoke-free tobacco; and wellness trends like perimenopause products and peptides. Confidential tips can be sent on Signal at sarahlizchar.47.

PR Newswire
Sep 22nd, 2026
OxiWear and Alfardan Medical with Northwestern Medicine (AMNM) announce exclusive distribution partnership in Qatar.

OxiWear and Alfardan Medical with Northwestern Medicine (AMNM) announce exclusive distribution partnership in Qatar. Sep 22, 2026, 17:30 ET Partnership marks an important step in OxiWear's international expansion and growing presence in the Middle East ARLINGTON, Va. and DOHA, Qatar, Sept. 22, 2026 /PRNewswire/ - OxiWear Inc., a wearable technology company focused on continuous physiological measurements, today announced an exclusive distribution partnership with Alfardan Medical with Northwestern Medicine (AMNM) in Qatar. The partnership brings together OxiWear's wearable measurement technology with AMNM's established presence, local expertise, and network in Qatar, supporting OxiWear's continued expansion across the Middle East. The partnership marks another milestone in OxiWear's international growth as the company continues to expand its technology and build strategic relationships across the United States and international markets. "Qatar has built an incredible ecosystem around technology and innovation, and we are excited to partner with AMNM as we continue expanding OxiWear internationally," said Shavini Fernando, Founder and CEO of OxiWear. "Having a strong local partner that understands the market and shares our long-term vision is incredibly important to us. We see significant opportunities for OxiWear in Qatar and across the region, and we look forward to working closely with Dr. Abdulla and the AMNM team to build that presence." Under the partnership, the organizations will collaborate on distribution, market development, customer engagement, and opportunities for OxiWear across Qatar. "We are pleased to partner with OxiWear and support the company's expansion into Qatar," said Dr. Abdulla Al-Ansari, CEO of AMNM. "Innovation and the introduction of new technologies are important to the continued development of Qatar's ecosystem. OxiWear's approach to continuous physiological measurements presents exciting opportunities across a range of applications, and we look forward to working together to establish and grow its presence in Qatar." The partnership is part of OxiWear's broader international expansion strategy and reflects the company's focus on establishing strong local relationships as it enters and develops new markets. About OxiWear: OxiWear Inc. is a wearable technology company developing solutions for continuous physiological measurements. Through its wearable technology and connected platform, OxiWear is building new ways to capture physiological data continuously across a range of environments and applications. Headquartered in Arlington, Virginia, OxiWear works with organizations and partners in the United States and internationally across research, performance, industrial, and other markets. Alfardan Medical with Northwestern Medicine (AMNM) is a multi-specialty private day-care surgery center located in Lusail, Qatar, operating in affiliation with Northwestern Medicine, the Chicago-based academic health system. AMNM brings together internationally trained physicians, advanced surgical facilities, and Northwestern Medicine's clinical standards to deliver high-quality, patient-centered outpatient care across a wide range of specialties. Committed to innovation and clinical excellence, AMNM works to introduce new medical technologies and best practices that advance healthcare in Qatar and the wider region. SOURCE OxiWear